Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • NEKTAR THERAPEUTICS Balance Sheet

  • View:
    Annual Data | Quarterly Data
    Period Ending FY2008 FY2007 FY2006 FY2005 FY2004
    Assets
    Cash and Short Term Investments 378.99 M 482.35 M 458.64 M 476.20 M 418.74 M
    Net Receivables 11.16 M 21.64 M 47.15 M 8.20 M 12.84 M
    Total Inventories 9.32 M 12.19 M 14.66 M 18.63 M 10.69 M
    Progress Payments & Others 0.00 0.00 0.00 0.00 0.00
    Prepaid Expenses — — — — —
    Other Current Assets 6.75 M 7.11 M 14.60 M 16.81 M 12.27 M
    Current Assets Total 406.22 M 523.28 M 535.04 M 519.84 M 454.54 M
    Long Term Receivables 0.00 0.00 0.00 0.00 0.00
    Investment in Unconsolidated Subsidiaries 0.00 0.00 0.00 0.00 0.00
    Other Investments 0.00 0.00 8.34 M 90.22 M 12.44 M
    Property, Plant & Equipment Net 73.58 M 114.42 M 133.81 M 142.13 M 151.25 M
    Property, Plant & Equipment Gross 117.08 M 220.67 M 240.41 M 228.87 M 214.92 M
    Accumulated Depreciation 43.50 M 106.25 M 106.60 M 86.74 M 63.67 M
    Other Assets 80.74 M 87.40 M 90.99 M 106.36 M 139.14 M
    Deferred Charges 13.15 M 2.17 M 6.76 M — —
    Tangible Other Assets 4.24 M 6.29 M 8.93 M 1.33 M 386,000.00
    Intangible Other Assets 76.50 M 81.11 M 82.06 M 91.88 M 136.58 M
    Total Assets 560.54 M 725.10 M 768.18 M 858.55 M 744.92 M
    Liabilities
    Short Term Debt & Current Portion of Long Term Debt 0.00 2.34 M 103.36 M 482,000.00 1.55 M
    Accrued Payroll 29.19 M 14.68 M 12.99 M 10.38 M 8.63 M
    Income Taxes Payable — — — — —
    Dividends Payable 0.00 0.00 0.00 0.00 0.00
    Other Current Liabilities 25.35 M 77.49 M 40.80 M 39.83 M 38.34 M
    Current Liabilities Total 68.37 M 98.09 M 165.31 M 69.60 M 55.65 M
    Long Term Debt 235.30 M 336.63 M 334.76 M 439.30 M 197.52 M
    Provision for Risks & Charges — — — — —
    Deferred Taxes 0.00 0.00 0.00 0.00 0.00
    Deferred Income 61.47 M 61.35 M 23.70 M 16.90 M 11.73 M
    Deferred Tax Liability in Untaxed Reserves — — — — —
    Other Liabilities 5.24 M 14.59 M 17.35 M 5.95 M 12.68 M
    Total Liabilities 370.38 M 510.66 M 541.12 M 531.74 M 277.58 M
    Shareholders Equity
    Non-Equity Reserves 0.00 0.00 0.00 0.00 0.00
    Minority Interest 0.00 0.00 0.00 0.00 0.00
    Preferred Stock 0.00 0.00 0.00 19.94 M 19.94 M
    Common Equity 190.15 M 214.44 M 227.06 M 306.87 M 447.40 M
    Common Stock 9,000.00 9,000.00 9,000.00 9,000.00 8,000.00
    Capital Surplus 1.31 B 1.30 B 1.28 B 1.21 B 1.17 B
    Revaluation Reserves 0.00 0.00 0.00 0.00 0.00
    Other Appropriated Reserves 1.44 M 0.00 -2.95 M -2.76 M -38,000.00
    Unappropriated (Free) Reserves 0.00 0.00 0.00 0.00 —
    Retained Earnings -1.12 B -1.09 B -1.06 B -902.23 M -717.12 M
    Equity in Untaxed Reserves — — — — —
    ESOP Guarantees 0.00 0.00 0.00 0.00 0.00
    Unrealized Foreign Exchange Gain (Loss) 1.22 M 561,000.00 250,000.00 1.50 M 708,000.00
    Unrealized Gain (Loss) on Marketable Securities 428,000.00 -499,000.00 -1.96 M -1.86 M 250,000.00
    Treasury Stock 0.00 0.00 0.00 0.00 0.00
    Total Liabilities & Shareholders Equity 560.54 M 725.10 M 768.18 M 858.55 M 744.92 M
    Common Shares Outstanding 92.50 M 92.30 M 91.28 M 87.71 M 84.57 M